A NEW CHEMICAL COMPOUND
    1.
    发明申请
    A NEW CHEMICAL COMPOUND 审中-公开
    新化学化合物

    公开(公告)号:WO1997026266A1

    公开(公告)日:1997-07-24

    申请号:PCT/SE1996001715

    申请日:1996-12-20

    Inventor: PERSTORP AB

    CPC classification number: C07F9/4081 C07F9/117 C07F9/144

    Abstract: The present invention relates to a chemical compound of formula (I) as a neutral or acidic salt thereof where the counter ions are Li , Na , K , Mg , Ca , NH4 or another pharmacologically acceptable positively charged inorganic or organic ion or any combination thereof and a pharmaceutical composition comprising as a pharmaceutically active ingredient at least one compound of formula (I).

    Abstract translation: 本发明涉及一种作为其中性或酸性盐的式(I)化合物,其中抗衡离子为Li +,Na +,K +,Mg 2+,Ca 2+, 或其它药学上可接受的带正电荷的无机或有机离子或其任何组合,以及包含至少一种式(I)化合物作为药物活性成分的药物组合物。

    A HETEROCYCLIC CHEMICAL COMPOUND
    6.
    发明申请
    A HETEROCYCLIC CHEMICAL COMPOUND 审中-公开
    杂环化学化合物

    公开(公告)号:WO1997018220A1

    公开(公告)日:1997-05-22

    申请号:PCT/SE1996001352

    申请日:1996-10-23

    Inventor: PERSTORP AB

    CPC classification number: C07F9/59 C07F9/572

    Abstract: A heterocyclic chemical compound of formula (1) or (2) or a neutral or acidic salt thereof where the counter ion is LI , Na , K , Mg , Ca , NH4 or another pharmacologically acceptable positively charged inorganic or organic ion or any combination thereof. The compound contains B, Si, N, P, S or Se in the ring structure.

    Abstract translation: 式(1)或(2)的杂环化合物或其中的中性或酸性盐,其中抗衡离子为LI +,Na +,K +,Mg 2+,Ca 2+, >,NH4 +或其他药理学上可接受的带正电荷的无机或有机离子或其任何组合。 该化合物在环结构中含有B,Si,N,P,S或Se。

    A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIO-AVAILABILITY OF INOSITOL PHOSPHATE
    7.
    发明申请
    A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIO-AVAILABILITY OF INOSITOL PHOSPHATE 审中-公开
    具有改善磷酸氢盐的生物可利用性的药物组合物

    公开(公告)号:WO1995019775A1

    公开(公告)日:1995-07-27

    申请号:PCT/SE1995000064

    申请日:1995-01-24

    Inventor: PERSTORP AB

    CPC classification number: A61K31/6615 A61K31/66 Y10S514/946

    Abstract: The invention relates to an inositol phosphate containing pharmaceutical composition which comprises an aliphatic ester or ether for improvement of the bioavailability of the inositol phosphate in mammals including man at non-parenteral administration. The invention also covers the use of at least one aliphatic ester or ether compound for the preparing of an inositol phosphate containing medicament with improved bioavailability of inositol phosphate in mammals including man at non-parenteral administration.

    Abstract translation: 本发明涉及含有肌醇磷酸酯的药物组合物,其包含脂肪族酯或醚,用于改善非肠胃外给药的哺乳动物中的肌醇磷酸酯的生物利用度。 本发明还涉及使用至少一种脂肪族酯或醚化合物来制备含有肌醇磷酸酯的药物,所述药物具有改善的哺乳动物中肌醇磷酸酯的生物利用度,包括非肠胃外给药的人。

Patent Agency Ranking